louisiana semaglutide gastric stasis lawsuit class action in Focus on Glucagon-like Peptide-1 Target: Drugs Approved or Designed to Treat Obesity Tirzepatide Deaths | Fatal Side

Concurrent Medications: Other prescriptions can sometimes interact with how the body absorbs or responds to GLP-1 agonists

Between reporting a drug is available and declaring a shortage is over, the FDAs drug shortages staff may communicate with manufacturers and wholesale distributors to confirm adequate supply and availability

Improper storage can significantly reduce the drugs effectiveness and potentially pose a safety risk

GLP-1 (Glucagon-Like Peptide-1) medications, such as semaglutide and trizepatide, are a class of drugs that have gained significant attention for their ability to promote weight loss

Freezing temperatures cause the peptide to break down, which means the medication will likely lose its potency and will not help you achieve your weight loss goals

While this may seem like bad news, this does not mean a blanket no for weight loss drugs